Article thumbnail

Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens

By T Bommenel, JL Meynard, O Launay, A Simon, A Mahamat, V Martinez, J Gilquin, C Katlama, AS Lascaux, C Pradier, E Rouveix, D Costagliola and S Abgrall
Topics: Oral Presentation
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles